Olivier Taelman
Net worth: 37 634 $ as of 2026-05-30
Net worth: 37 634 $ as of 2026-05-30
Olivier Taelman currently works at Nyxoah SA, as Chief Executive Officer & Executive Director from 2020.
Mr. Taelman also formerly worked at Nevro Corp., as Business Director-Neuromodulation from 2013 to 2015 and Autonomic Technologies, Inc., as Vice President-Europe from 2015 to 2019.
Mr. Taelman received his undergraduate degree from Hasselt University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NYXOAH SA 0.03% | 2026-02-28 | 12,500 ( 0.03% ) | 37 634 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| NYXOAH SA | Chief Executive Officer | 2019-10-31 |
| Companies | Position | End |
|---|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Corporate Officer/Principal | 2019-10-31 |
| NEVRO CORP. | Corporate Officer/Principal | 2015-11-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Hasselt University
Hasselt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevro Corp.
Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nyxoah SA
Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
Select your edition
All financial news and data tailored to specific country editions